Sandra Gellhaar

1.1k total citations
11 papers, 896 citations indexed

About

Sandra Gellhaar is a scholar working on Neurology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Sandra Gellhaar has authored 11 papers receiving a total of 896 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 8 papers in Cellular and Molecular Neuroscience and 4 papers in Physiology. Recurrent topics in Sandra Gellhaar's work include Parkinson's Disease Mechanisms and Treatments (8 papers), Nuclear Receptors and Signaling (3 papers) and Carbohydrate Chemistry and Synthesis (2 papers). Sandra Gellhaar is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (8 papers), Nuclear Receptors and Signaling (3 papers) and Carbohydrate Chemistry and Synthesis (2 papers). Sandra Gellhaar collaborates with scholars based in Sweden, United States and Switzerland. Sandra Gellhaar's co-authors include Dagmar Galter, Marie Westerlund, Homira Behbahani, Maria Ankarcrona, Caroline Graff, Pia Larssen, Annica Rönnbäck, Louise Hedskog, Laura Hertwig and Anna Sandebring and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The FASEB Journal and Human Molecular Genetics.

In The Last Decade

Sandra Gellhaar

11 papers receiving 890 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Gellhaar Sweden 10 465 340 317 288 169 11 896
Marie Westerlund Sweden 19 676 1.5× 411 1.2× 563 1.8× 385 1.3× 198 1.2× 28 1.3k
Francesca Longhena Italy 20 342 0.7× 262 0.8× 641 2.0× 385 1.3× 133 0.8× 33 1.1k
Aaron Daub United States 8 534 1.1× 396 1.2× 313 1.0× 296 1.0× 114 0.7× 9 1.0k
Géraldine Gelders Belgium 7 304 0.7× 242 0.7× 402 1.3× 166 0.6× 77 0.5× 7 838
Jeannette N. Stankowski United States 15 490 1.1× 260 0.8× 443 1.4× 233 0.8× 144 0.9× 17 1.0k
Matthias Höllerhage Germany 21 559 1.2× 440 1.3× 574 1.8× 331 1.1× 109 0.6× 42 1.4k
David X. Medina United States 13 448 1.0× 519 1.5× 163 0.5× 193 0.7× 132 0.8× 19 1.1k
Carmen R. Sunico Spain 13 428 0.9× 275 0.8× 137 0.4× 221 0.8× 73 0.4× 15 798
Natalie Connor‐Robson United Kingdom 18 350 0.8× 261 0.8× 690 2.2× 371 1.3× 153 0.9× 26 1.0k
Jens Waak Germany 8 401 0.9× 223 0.7× 489 1.5× 270 0.9× 76 0.4× 8 982

Countries citing papers authored by Sandra Gellhaar

Since Specialization
Citations

This map shows the geographic impact of Sandra Gellhaar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Gellhaar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Gellhaar more than expected).

Fields of papers citing papers by Sandra Gellhaar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Gellhaar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Gellhaar. The network helps show where Sandra Gellhaar may publish in the future.

Co-authorship network of co-authors of Sandra Gellhaar

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Gellhaar. A scholar is included among the top collaborators of Sandra Gellhaar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Gellhaar. Sandra Gellhaar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Ran, Caroline, Sandra Gellhaar, Marie Westerlund, et al.. (2022). Glucocerebrosidase variant T369M is not a risk factor for Parkinson’s disease in Sweden. Neuroscience Letters. 784. 136767–136767. 3 indexed citations
2.
Gellhaar, Sandra, et al.. (2017). Myeloperoxidase-immunoreactive cells are significantly increased in brain areas affected by neurodegeneration in Parkinson’s and Alzheimer’s disease. Cell and Tissue Research. 369(3). 445–454. 103 indexed citations
3.
Ran, Caroline, Lars Forsgren, Marie Westerlund, et al.. (2016). Strong association between glucocerebrosidase mutations and Parkinson's disease in Sweden. Neurobiology of Aging. 45. 212.e5–212.e11. 39 indexed citations
4.
Gellhaar, Sandra, Daniel Marcellino, Mathew Abrams, & Dagmar Galter. (2015). Chronic L‐DOPA induces hyperactivity, normalization of gait and dyskinetic behavior in MitoPark mice. Genes Brain & Behavior. 14(3). 260–270. 15 indexed citations
5.
Tsika, Elpida, Caroline S. Foo, Dustin Dikeman, et al.. (2014). Conditional expression of Parkinson's disease-related R1441C LRRK2 in midbrain dopaminergic neurons of mice causes nuclear abnormalities without neurodegeneration. Neurobiology of Disease. 71. 345–358. 60 indexed citations
6.
Häbig, Karina, Sandra Gellhaar, Florian Giesert, et al.. (2013). LRRK2 guides the actin cytoskeleton at growth cones together with ARHGEF7 and Tropomyosin 4. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1832(12). 2352–2367. 49 indexed citations
7.
Hedskog, Louise, Catarina Moreira Pinho, Riccardo Filadi, et al.. (2013). Modulation of the endoplasmic reticulum–mitochondria interface in Alzheimer’s disease and related models. Proceedings of the National Academy of Sciences. 110(19). 7916–7921. 409 indexed citations
8.
Daher, João Paulo Lima, Olga Pletniková, Saskia Biskup, et al.. (2012). Neurodegenerative phenotypes in an A53T  -synuclein transgenic mouse model are independent of LRRK2. Human Molecular Genetics. 21(11). 2420–2431. 75 indexed citations
9.
Anvret, Anna, Caroline Ran, Marie Westerlund, et al.. (2011). Adh1 and Adh1/4 knockout mice as possible rodent models for presymptomatic Parkinson's disease. Behavioural Brain Research. 227(1). 252–257. 9 indexed citations
10.
Good, Cameron H., Alexander F. Hoffman, Barry J. Hoffer, et al.. (2011). Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson's disease. The FASEB Journal. 25(4). 1333–1344. 112 indexed citations
11.
Westerlund, Marie, Homira Behbahani, Sandra Gellhaar, et al.. (2010). Altered enzymatic activity and allele frequency of OMI/HTRA2 in Alzheimer's disease. The FASEB Journal. 25(4). 1345–1352. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026